Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Prockop

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Cytotherapy|January 19, 2022
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipientsChristine Camacho-Bydume, Audrey Mauguen, M Irene Rodriguez-Sanchez, et al.
Blood Advances|May 23, 2022
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapyAisha N Hasan, Ekaterina Doubrovina, Rosa Sottile, et al.
The American Journal of Dermatopathology|June 20, 2015
Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant RecipientsAlyssa Fischer, Ann A Jakubowski, Mario E Lacouture, et al.
Cytotherapy|December 6, 2023
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyondSafia Belbachir, Allistair Abraham, Akshay Sharma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patientsJoanne Kurtzberg, Susan Prockop, Pierre Teira, et al.
Clinical Case Reports|November 29, 2023
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantationFranziska Wachter, Yana Pikman, Jacob Bledsoe, et al.
Cytotherapy|June 15, 2022
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatmentMaja Stanojevic, Alice Bertaina, Carmem Bonfim, et al.
Cytotherapy|January 29, 2023
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineeringOrly R Klein, Carmem Bonfim, Allistair Abraham, et al.
Cytotherapy|July 6, 2020
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantationIchelle van Roessel, Susan Prockop, Elizabeth Klein, et al.
Blood|June 10, 2006
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplantsDana Jaffe, Esperanza B Papadopoulos, James W Young, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Cytotherapy|January 19, 2022
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipientsChristine Camacho-Bydume, Audrey Mauguen, M Irene Rodriguez-Sanchez, et al.
Blood Advances|May 23, 2022
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapyAisha N Hasan, Ekaterina Doubrovina, Rosa Sottile, et al.
The American Journal of Dermatopathology|June 20, 2015
Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant RecipientsAlyssa Fischer, Ann A Jakubowski, Mario E Lacouture, et al.
Cytotherapy|December 6, 2023
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyondSafia Belbachir, Allistair Abraham, Akshay Sharma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patientsJoanne Kurtzberg, Susan Prockop, Pierre Teira, et al.
Clinical Case Reports|November 29, 2023
Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantationFranziska Wachter, Yana Pikman, Jacob Bledsoe, et al.
Cytotherapy|June 15, 2022
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatmentMaja Stanojevic, Alice Bertaina, Carmem Bonfim, et al.
Cytotherapy|January 29, 2023
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineeringOrly R Klein, Carmem Bonfim, Allistair Abraham, et al.
Cytotherapy|July 6, 2020
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantationIchelle van Roessel, Susan Prockop, Elizabeth Klein, et al.
Blood|June 10, 2006
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplantsDana Jaffe, Esperanza B Papadopoulos, James W Young, et al.
Pageof 7